Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1856

Actual shortage: 47 (3%)
Anticipated shortage: 6 (0%)
Avoided shortage: 13 (1%)
Resolved: 1790 (96%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

1 (2%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2020-12-07 2021-02-16 129727
NALOXONE HCL INJECTION - 1MG/ML USP 1MG LIQUID Resolved 2023-01-19 2023-03-21 181704
NALOXONE HCL INJECTION - 0.4MG/ML USP 0.4MG LIQUID Resolved 2017-03-21 2017-04-12 3820
NALOXONE HCL INJECTION - 0.4MG/ML USP 0.4MG LIQUID Avoided shortage 2017-03-21 2017-06-26 3823
S.O.S. NALOXONE HYDROCHLORIDE INJECTION 0.4MG SOLUTION Resolved 2017-03-21 2017-06-26 3826
NOREPINEPHRINE BITARTRATE INJECTION USP 1MG LIQUID Resolved 2018-01-08 2018-01-18 35329
NOREPINEPHRINE BITARTRATE INJECTION USP 1MG LIQUID Resolved 2022-04-20 2022-10-13 159100
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Resolved 2017-05-30 2017-10-18 11488
SANDOZ OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-26 2017-11-06 13932
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-26 2017-11-06 13935
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-26 2017-11-27 13938
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Resolved 2018-01-18 2018-02-05 36548
SANDOZ OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-02-12 2018-08-13 39569
SANDOZ OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-02-12 2018-08-13 39572
SANDOZ OLANZAPINE 5.0MG TABLET Resolved 2018-04-13 2018-05-23 45803
SANDOZ OLANZAPINE 15.0MG TABLET Resolved 2018-04-13 2018-07-03 45806
SANDOZ OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-13 2018-04-19 45809
SANDOZ OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-13 2018-04-19 45812
SANDOZ OLANZAPINE 15.0MG TABLET Resolved 2019-01-21 2019-01-30 73147
SANDOZ OLANZAPINE 7.5MG TABLET Resolved 2019-11-18 2020-01-08 99100

Showing 621 to 640 of 1856

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82